Indications for neurontin
Pro Research Analysisby 
Searched over 200M research papers
Indications for Neurontin (Gabapentin)
FDA-Approved Uses: Refractory Partial Seizures and Post-Herpetic Neuralgia
Gabapentin, marketed under the brand name Neurontin, is primarily approved by the FDA for two main indications: as an adjunctive therapy for refractory partial seizures and as an analgesic for post-herpetic neuralgia. In patients with refractory partial seizures, gabapentin has been shown to significantly reduce seizure frequency when used in combination with other antiepileptic drugs (AEDs) . Clinical studies have demonstrated that patients receiving gabapentin experienced a notable reduction in seizure frequency compared to those receiving a placebo, with responder rates indicating a significant proportion of patients achieving at least a 50% reduction in seizure frequency .
For post-herpetic neuralgia, gabapentin has proven to be an effective treatment option. Case studies have highlighted its efficacy in alleviating severe pain associated with this condition, offering a safer alternative to other treatments like carbamazepine or amitriptyline, especially in elderly patients .
Off-Label Uses: Pain Syndromes, Mood, and Anxiety Disorders
Beyond its FDA-approved uses, gabapentin is frequently prescribed off-label for a variety of other conditions. It is commonly used to manage different pain syndromes, including neuropathic pain, due to its ability to modulate neurotransmitter release by interacting with calcium channels . Additionally, gabapentin is often utilized in the treatment of mood and anxiety disorders, providing relief for patients who may not respond well to traditional therapies .
Abuse Potential and Diversion
While gabapentin is generally considered to have a low potential for abuse, there have been reports of its misuse, particularly among individuals who abuse prescription opioids. As the availability of commonly abused opioids decreases, some non-medical users have turned to gabapentin as an alternative substance for abuse . This trend underscores the importance of monitoring and regulating the prescription of gabapentin to prevent its diversion and misuse.
Conclusion
Gabapentin (Neurontin) is a versatile medication with FDA approval for the treatment of refractory partial seizures and post-herpetic neuralgia. Its off-label uses extend to various pain syndromes and mood and anxiety disorders, making it a valuable tool in the management of these conditions. However, the potential for abuse, particularly among opioid users, necessitates careful oversight to ensure its safe and effective use.
Sources and full results
Most relevant research papers on this topic